text
"['\n1. 요약재무정보\n가. 요약연결재무정보※ 당사는 당기 중 삼성바이오에피스㈜를 연결대상 종속기업으로 신규 편입하여,  \xa0 \xa0제12기 반기부터 해당 종속기업의 재무정보가 포함되었습니다.\r\n(단위 : 백만원)\n구분\n2022년(제12기)\n2021년(제11기)\n2020년(제10기)\n회계처리기준\nK-IFRS\nK-IFRS\nK-IFRS\n연결재무제표\n연결재무제표\n연결재무제표\n[유동자산]\n\xa0 \xa0 \xa0 \xa06,457,657\n2,823,175\n1,751,347\n현금및현금성자산\n\xa0 \xa0 \xa0 \xa0 \xa0890,820\n47,410\n28,850\n단기금융상품\n\xa0 \xa0 \xa0 \xa02,168,901\n450,000\n300,000\n당기손익-공정가치측정금융자산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa098,506\n850,040\n500,046\n유동자산-파생상품\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa013,478\n-\n-\n매출채권및기타채권\n\xa0 \xa0 \xa0 \xa0 \xa0732,839\n366,331\n217,932\n재고자산\n\xa0 \xa0 \xa0 \xa02,375,819\n1,012,871\n645,960\n기타유동금융자산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa035,311\n23,985\n23,556\n기타유동자산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa054,667\n8,627\n7,138\n계약자산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa087,316\n63,911\n27,865\n[비유동자산]\n\xa0 \xa0 \xa010,124,394\n5,146,836\n4,672,854\n장기금융상품\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 7,336\n190\n174\n관계기업및공동기업투자\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa030,775\n2,661,309\n2,634,428\n투자부동산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n-\n20,248\n유형자산\n\xa0 \xa0 \xa0 \xa03,416,529\n2,207,064\n1,736,567\n무형자산\n\xa0 \xa0 \xa0 \xa05,961,307\n32,172\n23,345\n사용권자산\n\xa0 \xa0 \xa0 \xa0 \xa0454,923\n20,624\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa024,160\n매출채권및기타채권\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa010,635\n4,428\n\xa0 \xa0 28,672\n순확정급여자산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa029,646\n3,572\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 11,900\n기타비유동금융자산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa032,092\n26,919\n23,184\n기타비유동자산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 3,524\n1,227\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa01,284\n계약자산\n\xa0 \xa0 \xa0 \xa0 \xa0177,627\n189,331\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0168,892\n\xa0 \xa0 \xa0 \xa0 자산총계\n\xa0 \xa0 \xa016,582,051\n7,970,011\n\xa0 \xa0 \xa0 \xa0 \xa0 6,424,201\n[유동부채]\n4,181,543\n1,107,295\n\xa0 \xa0 \xa0 \xa0589,301\n[비유동부채]\n3,416,034\n1,871,614\n\xa0 1,236,117\n\xa0 \xa0 \xa0 \xa0 부채총계\n7,597,577\n2,978,909\n\xa0 \xa0 \xa0 \xa0 1,825,418\n[지배기업 소유주지분]\n8,984,474\n4,991,102\n\xa0 \xa0 \xa04,598,783\n\xa0자본금\n177,935\n165,413\n\xa0 \xa0165,413\n\xa0자본잉여금\n5,663,111\n2,487,313\n\xa0 \xa0 \xa0 \xa0 \xa02,487,313\n\xa0기타포괄손익누계액\n(2,173)\n(8,811)\n(7,540)\n\xa0이익잉여금\n3,145,601\n2,347,187\n\xa0 \xa0 \xa0 \xa0 \xa01,953,597\n[비지배지분]\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\u3000 -\n\xa0-\n\xa0 \xa0 \xa0 \xa0자본총계\n8,984,474\n4,991,102\n\xa0 \xa0 \xa0 \xa0 4,598,783\n기간\n2022년 1월~12월\n2021년 1월~12월\n2020년 1월~12월\n매출액\n3,001,295\n1,568,007\n\xa0 \xa0 \xa0 \xa0 \xa01,164,777\n영업이익\n983,627\n537,309\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0292,787\n법인세비용차감전이익\n1,009,025\n561,283\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0265,992\n연결총당기순이익\n798,056\n393,589\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0240,975\n지배기업 소유주지분\n798,056\n393,589\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0240,975\n비지배지분\n-\n\xa0-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n기본주당순이익 (원)\n11,442\n5,949\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa03,642\n희석주당순이익 (원)\n11,432\n5,949\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa03,642\n연결에 포함된 회사수\n13개\n1개\n1개\n나. 요약별도재무정보※ 당사는 제10기(전전기) 중 종속기업이 설립됨에 따라, 2020년 1월 1일 이후 \xa0 \xa0개시하는 보고기간부터 별도재무제표를 작성하게 되었습니다.\xa0\r\n(단위 : 백만원)\n구분\n2022년 (제12기)\n2021년 (제11기)\n2020년(제10기)\n회계처리기준\nK-IFRS\nK-IFRS\nK-IFRS\n별도재무제표\n별도재무제표\n별도재무제표\n[유동자산]\n4,919,358\n2,814,680\n1,743,116\n\xa0현금및현금성자산\n757,946\n39,170\n20,460\n\xa0단기금융상품\n2,168,901\n450,000\n300,000\n\xa0당기손익-공정가치측정금융자산\n98,506\n850,040\n500,046\n\xa0매출채권및기타채권\n503,997\n366,338\n218,162\n\xa0재고자산\n1,243,172\n1,012,871\n645,960\n\xa0기타유동금융자산\n37,048\n23,984\n23,556\n\xa0기타유동자산\n13,964\n8,366\n7,067\n\xa0계약자산\n95,824\n63,911\n27,865\n[비유동자산]\n7,246,481\n3,088,732\n2,624,102\n\xa0장기금융상품\n5,187\n7\n7\n\xa0종속기업,관계기업및공동기업투자\n3,308,793\n541,389\n529,014\n\xa0투자부동산\n-\n-\n20,248\n\xa0유형자산\n3,083,545\n2,202,972\n1,734,019\n\xa0무형자산\n39,437\n32,152\n23,322\n\xa0사용권자산\n451,793\n17,884\n21,002\n\xa0매출채권및기타채권\n10,635\n4,428\n28,672\n\xa0순확정급여자산\n28,625\n3,572\n11,900\n\xa0기타비유동금융자산\n25,955\n26,920\n23,184\n\xa0기타비유동자산\n1,725\n1,227\n1,284\n\xa0계약자산\n208,516\n189,331\n168,892\n\xa0이연법인세자산\n82,270\n68,850\n62,558\n\xa0 \xa0 \xa0 \xa0 자산총계\n12,165,839\n5,903,412\n4,367,218\n[유동부채]\n2,990,677\n1,106,401\n588,727\n[비유동부채]\n1,878,559\n1,381,739\n783,650\n\xa0 \xa0 \xa0 \xa0 부채총계\n4,869,236\n2,488,140\n1,372,377\n[자본금]\n177,935\n165,413\n165,413\n[자본잉여금]\n5,672,425\n2,496,627\n2,496,627\n[기타포괄손익누계액]\n(6,726)\n(12,944)\n(10,198)\n[이익잉여금]\n1,452,969\n766,176\n342,999\n\xa0 \xa0 \xa0 \xa0자본총계\n7,296,603\n3,415,272\n2,994,841\n종속ㆍ관계ㆍ공동기업투자주식의 평가방법\n원가법\n원가법\n원가법\n기간\n2022년 1월~12월\n2021년 1월~12월\n2020년 1월~12월\n매출액\n2,437,286\n1,568,007\n1,164,777\n영업이익\n968,051\n536,495\n292,589\n법인세비용차감전이익\n922,887\n546,863\n280,889\n당기순이익\n686,793\n423,177\n250,969\n기본주당순이익 (원)\n9,847\n6,396\n3,793\n희석주당순이익 (원)\n9,838\n6,396\n3,793\n']"
